| Brittany Royer, OT | |
|
1411 S Creasy Ln Ste 100, Lafayette, IN 47905-7433 | |
| (765) 447-5552 | |
| (765) 449-1054 |
| Full Name | Brittany Royer |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapy |
| Experience | 6 Years |
| Location | 1411 S Creasy Ln Ste 100, Lafayette, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205310729 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 31006751A (Indiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Unity Healthcare Llc | 0244123362 | 76 |
News Archive
According to Bloomberg, the report by Jackson Hewitt Tax Service Inc. estimates the cost to employers to be $1 billion. Meanwhile, other news outlets report on state-level decisions and developments related to the expansion.
Picture yourself in a medical office, anxiously awaiting your annual flu shot. The nurse casually states, "This won't hurt a bit." But when the needle pierces your skin it hurts, and it hurts a lot. Your expectations have been violated, and not in a good way.
ISTA Pharmaceuticals, Inc., today announced it has initiated a Phase 1/2 clinical study of bepotastine besilate nasal spray for the treatment of symptoms associated with seasonal allergic rhinitis, the inflammation of the nasal passages caused by allergies. The randomized, placebo-controlled, parallel-group study will evaluate the safety and efficacy of three concentrations of bepotastine besilate, dosed twice daily, in an Environmental Exposure Chamber model of allergic rhinitis caused by natural exposure to seasonal allergens.
Researchers have been working at growing tissue and organs in the laboratory for a long time. These days, tissue engineering enables us to build up artificial tissue, although science still hasn't been successful with larger organs. Now, researchers at Fraunhofer are applying new techniques and materials to come up with artificial blood vessels in their BioRap project that will be able to supply artificial tissue and maybe even complex organs in future.
› Verified 1 days ago
| Provider Name | Arnett Clinic Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1164490843 PECOS PAC ID: 0749184380 Enrollment ID: O20031125000119 |
News Archive
According to Bloomberg, the report by Jackson Hewitt Tax Service Inc. estimates the cost to employers to be $1 billion. Meanwhile, other news outlets report on state-level decisions and developments related to the expansion.
Picture yourself in a medical office, anxiously awaiting your annual flu shot. The nurse casually states, "This won't hurt a bit." But when the needle pierces your skin it hurts, and it hurts a lot. Your expectations have been violated, and not in a good way.
ISTA Pharmaceuticals, Inc., today announced it has initiated a Phase 1/2 clinical study of bepotastine besilate nasal spray for the treatment of symptoms associated with seasonal allergic rhinitis, the inflammation of the nasal passages caused by allergies. The randomized, placebo-controlled, parallel-group study will evaluate the safety and efficacy of three concentrations of bepotastine besilate, dosed twice daily, in an Environmental Exposure Chamber model of allergic rhinitis caused by natural exposure to seasonal allergens.
Researchers have been working at growing tissue and organs in the laboratory for a long time. These days, tissue engineering enables us to build up artificial tissue, although science still hasn't been successful with larger organs. Now, researchers at Fraunhofer are applying new techniques and materials to come up with artificial blood vessels in their BioRap project that will be able to supply artificial tissue and maybe even complex organs in future.
› Verified 1 days ago
| Provider Name | Unity Healthcare Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1619929098 PECOS PAC ID: 0244123362 Enrollment ID: O20040203001083 |
News Archive
According to Bloomberg, the report by Jackson Hewitt Tax Service Inc. estimates the cost to employers to be $1 billion. Meanwhile, other news outlets report on state-level decisions and developments related to the expansion.
Picture yourself in a medical office, anxiously awaiting your annual flu shot. The nurse casually states, "This won't hurt a bit." But when the needle pierces your skin it hurts, and it hurts a lot. Your expectations have been violated, and not in a good way.
ISTA Pharmaceuticals, Inc., today announced it has initiated a Phase 1/2 clinical study of bepotastine besilate nasal spray for the treatment of symptoms associated with seasonal allergic rhinitis, the inflammation of the nasal passages caused by allergies. The randomized, placebo-controlled, parallel-group study will evaluate the safety and efficacy of three concentrations of bepotastine besilate, dosed twice daily, in an Environmental Exposure Chamber model of allergic rhinitis caused by natural exposure to seasonal allergens.
Researchers have been working at growing tissue and organs in the laboratory for a long time. These days, tissue engineering enables us to build up artificial tissue, although science still hasn't been successful with larger organs. Now, researchers at Fraunhofer are applying new techniques and materials to come up with artificial blood vessels in their BioRap project that will be able to supply artificial tissue and maybe even complex organs in future.
› Verified 1 days ago
| Provider Name | Ivyrehab Physical Therapy Pllc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1750764494 PECOS PAC ID: 7012997638 Enrollment ID: O20151211000959 |
News Archive
According to Bloomberg, the report by Jackson Hewitt Tax Service Inc. estimates the cost to employers to be $1 billion. Meanwhile, other news outlets report on state-level decisions and developments related to the expansion.
Picture yourself in a medical office, anxiously awaiting your annual flu shot. The nurse casually states, "This won't hurt a bit." But when the needle pierces your skin it hurts, and it hurts a lot. Your expectations have been violated, and not in a good way.
ISTA Pharmaceuticals, Inc., today announced it has initiated a Phase 1/2 clinical study of bepotastine besilate nasal spray for the treatment of symptoms associated with seasonal allergic rhinitis, the inflammation of the nasal passages caused by allergies. The randomized, placebo-controlled, parallel-group study will evaluate the safety and efficacy of three concentrations of bepotastine besilate, dosed twice daily, in an Environmental Exposure Chamber model of allergic rhinitis caused by natural exposure to seasonal allergens.
Researchers have been working at growing tissue and organs in the laboratory for a long time. These days, tissue engineering enables us to build up artificial tissue, although science still hasn't been successful with larger organs. Now, researchers at Fraunhofer are applying new techniques and materials to come up with artificial blood vessels in their BioRap project that will be able to supply artificial tissue and maybe even complex organs in future.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Brittany Royer, OT Po Box 4699, Lafayette, IN 47903-4699 Ph: (765) 446-5417 | Brittany Royer, OT 1411 S Creasy Ln Ste 100, Lafayette, IN 47905-7433 Ph: (765) 447-5552 |
News Archive
According to Bloomberg, the report by Jackson Hewitt Tax Service Inc. estimates the cost to employers to be $1 billion. Meanwhile, other news outlets report on state-level decisions and developments related to the expansion.
Picture yourself in a medical office, anxiously awaiting your annual flu shot. The nurse casually states, "This won't hurt a bit." But when the needle pierces your skin it hurts, and it hurts a lot. Your expectations have been violated, and not in a good way.
ISTA Pharmaceuticals, Inc., today announced it has initiated a Phase 1/2 clinical study of bepotastine besilate nasal spray for the treatment of symptoms associated with seasonal allergic rhinitis, the inflammation of the nasal passages caused by allergies. The randomized, placebo-controlled, parallel-group study will evaluate the safety and efficacy of three concentrations of bepotastine besilate, dosed twice daily, in an Environmental Exposure Chamber model of allergic rhinitis caused by natural exposure to seasonal allergens.
Researchers have been working at growing tissue and organs in the laboratory for a long time. These days, tissue engineering enables us to build up artificial tissue, although science still hasn't been successful with larger organs. Now, researchers at Fraunhofer are applying new techniques and materials to come up with artificial blood vessels in their BioRap project that will be able to supply artificial tissue and maybe even complex organs in future.
› Verified 1 days ago
Caitlin Smedema, OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 1701 S Creasy Ln, Lafayette, IN 47905 Phone: 000-000-0000 | |
Lauren Ashley Hazel, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 35 Executive Dr Ste 5, Lafayette, IN 47905 Phone: 765-446-8300 | |
Stacy Lynn Lokke, M.S., OTR Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 3746 Rome Dr, Lafayette, IN 47905 Phone: 765-448-8000 Fax: 765-448-8702 | |
Mrs. Shannon Marie Heitmiller, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1260 N 17th St, Lafayette, IN 47904 Phone: 765-423-6885 Fax: 765-423-6099 | |
Mrs. Corry Lynn Voll, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2400 South St, Home Hospital Rehabilitation Unit, Lafayette, IN 47904 Phone: 765-449-5106 | |
Anne-marie Florich-brown, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 35 Executive Dr Ste 5, Lafayette, IN 47905 Phone: 765-446-8300 | |
Mukesh Malhotra, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3746 Rome Dr, Lafayette, IN 47905 Phone: 765-448-8000 |